Sugi Holdings Co.,Ltd. (SGIPF)
ValueMarkers Composite Index
98% below intrinsic value ($815)
Sugi Holdings Co.,Ltd. (SGIPF) — VMCI valuation read
Across 120 indicators, Sugi Holdings Co.,Ltd. (SGIPF) lands at VMCI 62/100. The Healthcare sector median is 50, so the 12-point above-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.
No material Form 4 disclosures landed on SGIPF in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.
**Investor frame.** On Value, SGIPF trades at 17.0x earnings, 6% below the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 17.0% sits 7.0pp above the Healthcare median (10.0%). On Risk, net debt to EBITDA of 2.0x is the rate-sensitivity line to watch for SGIPF on the trailing balance sheet.
SGIPF fell 3.0% over the trailing 7 days, with a -15.2% read on a 30-day basis.
Sugi Holdings Co.,Ltd. operates drugstores in Japan. It also provides health counseling services; home-visit prescription dispensing and nursing services; medical consulting; staff agency services; disabled employment promotion; and elderly home care support services. The company operates approximately 1,483 drugstores. Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.